Aigen Investment Management’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.57M Buy
7,747
+7,169
+1,240% +$3.63M 0.92% 13
2025
Q4
$327K Sell
578
-7,371
-93% -$3.92M 0.08% 338
2025
Q3
$3.56M Buy
7,949
+6,230
+362% +$2.99M 0.55% 20
2025
Q2
$934K Buy
1,719
+994
+137% +$520K 0.13% 260
2025
Q1
$359K Buy
+725
New +$401K 0.06% 441
2024
Q2
Sell
-1,251
Closed -$499K 902
2024
Q1
$499K Buy
+1,251
New +$473K 0.11% 280
2022
Q4
Sell
-18,387
Closed -$3.45M 655
2022
Q3
$3.45M Sell
18,387
-8,518
-32% -$1.83M 0.49% 54
2022
Q2
$5.4M Buy
+26,905
New +$6.31M 0.91% 14
2022
Q1
Sell
-1,846
Closed -$635K 811
2021
Q4
$635K Buy
+1,846
New +$635K 0.04% 554
2020
Q1
Sell
-369
Closed -$73K 1405
2019
Q4
$73K Buy
+369
New +$69.1K 0.01% 740

Other funds holding ISRG

Aigen Investment Management's ISRG Position: Q1 2026 in Review

Aigen Investment Management increased its Intuitive Surgical (ISRG) stake by 1,240% in Q1 2026, buying an estimated $3.63M and bringing the position to 7,747 shares worth $3.57M. The position accounts for 0.92% of the portfolio, ranked #13.

Aigen Investment Management first reported a position in ISRG in Q4 2019 and has held it in 10 quarters since. The position peaked at $5.4M in Q2 2022. 2,303 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

  • Aigen Investment Management held 7,747 shares of Intuitive Surgical worth $3.57M as of Q1 2026.
  • Aigen Investment Management bought 7,169 Intuitive Surgical shares in Q1 2026, an estimated $3.63M.
  • Intuitive Surgical made up 0.92% of Aigen Investment Management's portfolio in Q1 2026, its #13 holding.
  • Aigen Investment Management first reported a position in Intuitive Surgical in Q4 2019 and has held it in 10 quarters since.
  • Aigen Investment Management's Intuitive Surgical position peaked at $5.4M in Q2 2022.
  • 2,303 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on Aigen Investment Management's 13F filing for Q1 2026, filed 15 May 2026.